Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
E-pub ahead of print

Hypo-METRICS: Hypoglycaemia - MEasurement, ThResholds and ImpaCtS - A multi-country clinical study to define the optimal threshold and duration of sensor-detected hypoglycaemia that impact the experience of hypoglycaemia, quality of life and health economic outcomes: the study protocol

Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

DOI

  • Patrick Divilly
  • Natalie Zaremba
  • Zeinab Mahmoudi
  • Uffe Søholm
  • Daniel J Pollard
  • Melanie Broadley
  • Evertine J Abbink
  • Bastiaan de Galan
  • Ulrik Pedersen-Bjergaard
  • Eric Renard
  • Mark Evans
  • Jane Speight
  • Alan Brennan
  • Rory J McCrimmon
  • Matthias Müllenborn
  • Simon Heller
  • Alexander Seibold
  • Julia K Mader
  • Stephanie A Amiel
  • Frans Pouwer
  • Pratik Choudhary
  • Hypo-RESOLVE consortium
Vis graf over relationer

INTRODUCTION: Hypoglycaemia is a significant burden to people living with diabetes and an impediment to achieving optimal glycaemic outcomes. The use of continuous glucose monitoring (CGM) has improved the capacity to assess duration and level of hypoglycaemia. The personal impact of sensor-detected hypoglycaemia (SDH) is unclear. Hypo-METRICS is an observational study designed to define the threshold and duration of sensor glucose that provides the optimal sensitivity and specificity for events that people living with diabetes experience as hypoglycaemia.

METHODS: We will recruit 600 participants: 350 with insulin-treated type 2 diabetes, 200 with type 1 diabetes and awareness of hypoglycaemia and 50 with type 1 diabetes and impaired awareness of hypoglycaemia who have recent experience of hypoglycaemia. Participants will wear a blinded CGM device and an actigraphy monitor to differentiate awake and sleep times for 10 weeks. Participants will be asked to complete three short surveys each day using a bespoke mobile phone app, a technique known as ecological momentary assessment. Participants will also record all episodes of self-detected hypoglycaemia on the mobile app. We will use particle Markov chain Monte Carlo optimization to identify the optimal threshold and duration of SDH that have optimum sensitivity and specificity for detecting patient-reported hypoglycaemia. Key secondary objectives include measuring the impact of symptomatic and asymptomatic SDH on daily functioning and health economic outcomes.

ETHICS AND DISSEMINATION: The protocol was approved by local ethical boards in all participating centres. Study results will be shared with participants, in peer-reviewed journal publications and conference presentations.

OriginalsprogEngelsk
TidsskriftDiabetic medicine : a journal of the British Diabetic Association
Sider (fra-til)e14892
ISSN0742-3071
DOI
StatusE-pub ahead of print - 22 jun. 2022

Bibliografisk note

This article is protected by copyright. All rights reserved.

ID: 78297262